Who we are – Who we will be  by Lytle, Bruce W.
Vol. 135, No. 5, May 2008
Who we are – Who we will be
Bruce W. Lytle, MD
I
t is a privilege for me to be a cardiothoracic surgeon and it is an honor to speak to
you today. During this time I would like to think about our future, some of the
changes we will witness in the future, and some of the things we will need to be-
come. Also, I would like to think about the foundations of what we are, our core values
and skills. One of the core values of cardiothoracic surgery has been mentorship. None
of us has made this journey alone. In my life and career I have had great mentors, and I
have needed them. My father, Francis Lytle, was a physician in Fargo, North Dakota,
who taught me the responsibilities of being a physician. In this photograph he is with
his young son on a prairie trail (Figure 1). His death at far too early an age from
cardiovascular disease gave me a mission for my life. This is a picture of some of
friends that I grew up with, along with our prize possessions—guns and pickup trucks
(Figure 2). These guys ended up being everything from cops to astronauts. They are
my friends and mentors today. They keep me real, and on a few occasions where I
think that I may have at least some of the answers to some of the questions, they
remind me of the time I drove the pickup into the slough.
After college and medical school, I was fortunate enough to be accepted into the
general surgical training program at the Massachusetts General Hospital, headed by
W. Gerald Austin. This was a wonderful place and I am grateful to many of the faculty
who did the best they could with me. I am also very grateful to my fellow residents and
the tremendous impact that they had on me and my career (Figure 3). Terry McEnany,
Willis Williams, Cary Akins, Al Hilgenberg, Robert Guyton, Jim Kirklin, Gus
Vlahakes, and Doug Mathisen, all members of The American Association for Tho-
racic Surgery (AATS), and many more residents, were people from whom I learned
a great deal and from whom I am still learning today. The faculty during my cardio-
thoracic training included Hermes Grillo, Earl Wilkins, Gordon Scannell, Ashby
Moncure, and Willard Daggett. They very generously shared with me great patience
and insight. For most of us, however, there is someone who brings everything to-
gether, and for me that person was Mortimer J. Buckley, our 76th president (Figure 4).
Dr Buckley is correctly known as one of the great educators of our time, and I am par-
ticularly appreciative because I needed more education than most. Although many of
the techniques that I was taught have changed with time, the lessons about a steadfast-
ness of purpose and the totality of commitment remain, and time has not diminished
my gratitude to Dr Buckley.
I was recruited to The Cleveland Clinic during the tenure of Dr Floyd Loop as chair-
man of the Department of Cardiothoracic Surgery (Figure 5). He made it absolutely clear
that he had an expectation that I was going to write. It was very important for this young
surgeon to be given that clear direction. Dr Loop also taught me to use the interrupted
silk technique for coronary surgery, and I have really never forgiven him for that.
Dr Toby Cosgrove (Figure 6) was my colleague as a resident, preceded me to The
Cleveland Clinic, and was one of the reasons that I ended up there. He has been a col-
league and friend for more than 35 years. This long interaction has been entirely to my
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Presidential Address Lytlebenefit, and my life and career have been greatly enhanced by
this collaboration and friendship.
One of the great joys of my life is that I work with a won-
derful group of surgeons at The Cleveland Clinic (Figure 7).
There are a lot of them, you know them all, and you will
know them even better in the future. They are committed, in-
telligent, collegial people and they make my life a joy. I learn
something from them everyday. We also have a group of
long-term employees, nurses, surgical assistants, and secre-
taries who really are the heart of our organization.
Finally, it is possible for me to have my career because of
my wife, Suzanne. She has been incredibly supportive from
the day we were married, and even for a few days before
that. The home that she created for our children, for me,
and for our dogs was real magic. It sort of went along its
own serene way regardless of me and my very irregular
appearances, but it allowed me to be what I am. Here we
are last Christmas with our children, Ted and his wife,
Sara, our grandson Hudson, my daughter Medora and my
son-in-law, Kevin, and our dogs (Figure 8). The dogs are
in their normal position, very close to the food. I have a friend
who tells me often that if there is such a thing as reincarnation
he wants to return as one of Suzanne’s dogs. So do I.
My friends and colleagues, cardiothoracic surgery is a spe-
cialty that is small in numbers but that has had a huge impact
on the treatment of cardiovascular and thoracic disease and
Figure 1. Francis T. Lytle and Bruce W. Lytle on a North Dakota
country road.
Figure 2. I am pictured, at left, with friends in a Dakota winter.966 The Journal of Thoracic and Cardiovascular Surgery c Mayon medicine in general. Many decades ago cardiac surgery
led medicine into an era of technology-based health care.
The idea that a person’s circulation and oxygenation could
be maintained by a machine while a complicated surgical
operation is performed inside the heart was stunning in the
late 1950s, and it broke down a lot of psychological barriers
to the application of technology in all areas of medicine.
Cardiothoracic surgery has contributed to some very
profound economic and social changes. The development of
coronary surgery meant there was an effective anatomic treat-
ment for coronary artery disease, which, at that time, was the
single most common cause of premature death in America.
The passage of the Medicare/Medicaid Act in 1965 meant
that doctors and hospitals could be compensated for doing
it. As we look back over the past 30 years, we should recog-
nize that a huge expansion of the medical infrastructure in
Figure 3. Resident staff with W. Gerald Austin, MD, Massachu-
setts General Hospital, 1977.
Figure 4. Mortimer J. Buckley, MD, 76th president of the AATS and
my surgical mentor.2008
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small, medical facilities have grown dramatically in size and
in social and economic importance. Often, cardiac surgery
was the economic engine that fueled that growth.
Today, however, we are at an inflection point. Things are
changing. Some of those changes involve the treatment of
Figure 5. Floyd D. Loop, MD, 78th president of the AATS, former
chairman of the Department of Cardiovascular and Thoracic Sur-
gery, and chief executive officer of The Cleveland Clinic Founda-
tion. Dr Loop understood academic pursuit to be part of the
surgeons' mission.
Figure 6. Delos M. Cosgrove, MD, 80th president of the AATS,
chairman of the Department of Cardiovascular and Thoracic Sur-
gery, and chief executive officer of The Cleveland Clinic Founda-
tion. Colleague, friend, and mentor for over 35 years.The Journal of Thorcardiovascular disease, and some involve the environment
in which medicine is practiced, taught, and learned. Among
the trends that we currently recognize are a diminishing num-
ber of bypass operations, declining reimbursement, a diffu-
sion of technology from academic to community hospitals,
a stream of new technologies with potentially strong impact
on the treatment of cardiovascular diseases, changes in the
motivation of medical students and young physicians, and
declining interest of those graduates in our specialty.
But the issue that directly affects our professional lives on
the most basic level is that today cardiothoracic surgeons are
not the only physicians engaged in the anatomic treatment of
cardiothoracic disease. Many other specialties use some kind
of anatomic treatment for cardiothoracic disease, most often
catheter based. These alternative strategies are usually
described by their proponents as less invasive, less morbid,
and less inconvenient than the open surgical operations that
are the core of our expertise. In some cases, they are at least
partially correct. Those of us in this room respond by pointing
out the proven and excellent long-term outcomes of open sur-
gery. However, a fact we must reckon with is that young phy-
sicians are less and less interested in our specialty. This trend
has multiple causes, some of which we may understand and
some of which we may not, but the one cause that we need to
understand is the perception by young physicians that the
importance and value of cardiothoracic surgery is declining.
Figure 7. Department of Cardiovascular and Thoracic Surgery, The
Cleveland Clinic Foundation surgical staff, 2006.
Figure 8. My family, Christmas 2006.acic and Cardiovascular Surgery c Volume 135, Number 5 967
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extent that the physicians in that specialty provide effective
patient care. The value and importance of cardiothoracic sur-
geons, of our professional societies, our scientific sessions,
and our opinions derive from the benefit that patients experi-
ence from our work. In the past, that benefit has been great. In
the future, our value and importance will be related to the
extent that we can employ both old and new technologies
for patient benefit.
Part of what I would like to talk about today is future tech-
nology and our role in it. But I would also like to think about
some things that are fundamental to who we are and what we
are, the core values and skills of cardiothoracic surgery. What
makes us different from cardiologists or radiologists? We are
different, you and I, from other physicians. Whether those dif-
ferences are due to our heritage or to our training or to the
types of people that become cardiac surgeons or some combi-
nation of these things, I do not know. But I think that they are
real and, in a world of change, I believe they are of enduring
importance. Most of this discussion will relate to adult cardiac
surgery, partially because that is where I have been most
involved and partially because it is the area of most immediate
concern. However, many of the same issues apply to congen-
ital heart surgery and to general thoracic surgery.
Of all the characteristics of cardiac surgery, the most salient
is that it is a serious business and the people who do it success-
fully are serious people. That sounds trite, but I do not think
that it is. Some of that seriousness may be related to the fact
that survival is the issue at stake, and some of that seriousness
may be related to the assumption of personal responsibility by
the cardiac surgeon, another defining characteristic. Cardiac
surgeons are personally and identifiably responsible for out-
comes. The position of the cardiac surgeon has been and
will continue to be that of the patient’s last chance. In the
end there is no one else to whom we can pass the ball.
Another important characteristic of cardiac surgeons is the
demand for technical excellence and a belief that technical ex-
cellence matters. Traditionally, residents choosing a career in
cardiac surgery have been among the most technically gifted
and focused, and they train for a long time to become skillful
at the varied and complex reconstructions that make up cardiac
surgery. There is a wonderful and terrible reality associated with
cardiac surgery. No matter what someone says can be done, the
surgeon must actually go and do it and make it work. If it does
not work, you usually find out about it sooner rather than later.
Cardiac surgery is not generic and you cannot fake it.
Leadership, and in particular leadership of the cardiac sur-
gical team, has been extremely important. Cardiac surgical op-
erations involve complex interactions among a large number
of people with different skill sets, including nurses, perfusion-
ists, operative assistants, anesthesiologists, and the surgeon.
The development of the operating room team, the coordination
of their efforts, and the continued strong and stable leadership
have been important characteristics of successful cardiac sur-968 The Journal of Thoracic and Cardiovascular Surgery c Mgeons and have enabled highly reproducible outcomes to be
achieved. The team approach to surgery has been an important
contribution and also has extended to postoperative care.
Cardiac surgeons have maintained a persistent involvement
with postoperative care and understand that the effectiveness
of critical care is reflected in the overall outcomes.
The careful and persistent study of patient outcomes and
the factors affecting those outcomes is an important part of
what we are today and what we must continue to be in the
future. Early in the history of cardiac surgery, follow-up stud-
ies of patients after valve replacement set a standard for
longitudinal observational studies. The randomized trials of
coronary bypass surgery versus medical management were
landmarks in the evaluation of invasive therapies and were
the first studies that documented the benefits of a surgical pro-
cedure relative to medical treatment. These trials were
heavily criticized at the time, but in the end they did show
that bypass surgery prolonged the life expectancy of some
definable patient populations and relieved angina for most
patients. Today, these studies are still great assets and provide
some of the basis of the indications for bypass surgery. Sim-
ilarly, the trials of bypass surgery versus percutaneous treat-
ments have been criticized but, again, in retrospect, have
provided a strong body of evidence for the safety, stability,
and superiority of surgical treatment. Observational data
from state registries and single institution registries, often
laboriously maintained by cardiac surgeons, have confirmed
and extended the data regarding the benefits of bypass sur-
gery. Today, it seems that sometimes there is an overwhelm-
ing demand for information and a whole lot less appreciation
for the truth. It can be frustrating to all of us to witness data
being ignored and practice patterns deviating from those that
evidence seems to dictate. However, we cannot be discour-
aged. We must continue to be engaged in the study of out-
comes. The truth is our greatest ally. Every cardiac surgeon
must be an academic surgeon, must be able to understand
and to credibly discuss data that relate to the treatment of
cardiovascular disease. This is important on every level,
from a national meeting to an individual discussion in the
hospital hallway.
The study of outcomes has helped us to achieve better
outcomes. Process improvement based on data is another
area in which cardiac surgery has been a model for all of med-
icine. Contributions in this area have been made by many
surgeons, but particularly noteworthy was the work done
by Drs John Kirklin and Eugene Blackstone, whose develop-
ment of the initial guidelines for coronary bypass surgery for
the American College of Cardiology/American Heart Associ-
ation helped to set standards in this area. More recently, The
Society of Thoracic Surgeons (STS) Database has evolved
into a valuable resource for the study and improvement of
the processes of care for cardiac surgical patients.
The high level of intellectual credibility that has been
characteristic of these efforts in the past will continue to beay 2008
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particularly the patient, is bombarded with information. We
will not be able to be the source of the largest amount of
information, but we must be the source of the best informa-
tion. In the past, there has been justifiable criticism of some
of our scientific sessions: they lack ‘‘buzz’’ and they do not
have the excitement of interventionally based meetings.
Some of those criticisms are correct. Every advance in med-
icine is at some point just a good idea. I think we now under-
stand that in our national meetings there needs to be room for
the unproven great idea and for the exploration of possibili-
ties as well as known outcomes. However, we also need to
be able to distinguish between them. Trivialization of our
academic processes will not make us more innovative.
The core values of cardiac surgery have been seriousness,
personal responsibility, technical excellence, intellectual
credibility, leadership, and mentoring. Our core skills have
been complex cardiac reconstructions, including aortic and
mitral valve replacement and repair, coronary revasculariza-
tion, and thoracic aortic surgery, with these procedures often
supported by cardiopulmonary bypass. These operations
have provided great benefit to thousands of patients, and
we love to do them. However, we now realize that they
will not be the only valuable anatomic treatments for cardio-
vascular disease in the future.
For example, endovascular procedures will be a major part
of the future of aortic surgery. An elderly patient with multiple
comorbidities was maintained at home on supplemental oxy-
gen (see Video 1) with an extensive aneurysm (Figure 9, A).
This patient was treated with a stent graft of the entire thora-The Journal of Thorcoabdominal aorta, which included multiple visceral
branches (Figure 9, B). He was in the hospital for 4 days
and is well more than a year after the operation. A 350-pound
man with a previous aortic dissection and a contained rupture
in the area of the isthmus was treated on an emergency basis
by my colleague, Dr Eric Roselli. First, through a median ster-
notomy incision, a debranching operation revascularized the
upper extremity and cerebral vessels (Figure 10, A). Dr Rose-
lli then stented the arch and descending aorta down to the ce-
liac artery (Figure 10, B), ending up with the result shown in
Figure 10,C. Dr Roselli was trained for a year in endografting
by our vascular surgical colleagues and in coronary angiogra-
phy and is now carrying out these procedures within a center
that includes cardiac and vascular surgery. These operations
are not easy to perform and the devices have to get better,
but the potential for endografting to decrease the procedure-
related risks of these major operations is striking.
For many cardiac surgeons, the treatment of aortic disease
other than the ascending aorta is not a huge issue. The treat-
ment of valvular heart disease is a huge issue for everybody.
Today, there are a myriad of catheter-borne devices designed
for the treatment of valvular heart disease. Most of them are
in some form of developmental stage, but both a mitral repair
device and a catheter-borne aortic valve prosthesis are
currently in pivotal randomized trials in the United States.
In Europe there are many more such devices.
Video 1 shows a Cleveland Clinic patient undergoing im-
plantation of a catheter-borne aortic valve. This procedure
was done via an iliac artery exposure because of the presence
of severe peripheral vascular disease (Figure 11, A). TheFigure 9. Chronic thoracoabdominal aneurysm
(A) treated with 1-stage endografting including
branch grafts (B).acic and Cardiovascular Surgery c Volume 135, Number 5 969
Presidential Address LytleFigure 10. Chronic dissection after repair of type A acute dissection (A).This patient was treatedwith "debranching''
of the cerebral vessels (B) and stenting of the arch and thoracoabdominal aorta (C).balloon was inflated to fix the valve into the annulus, and with
that maneuver the left main coronary artery became occluded
by the calcified left coronary cusp (Figure 11, B). Not surpris-
ingly, hypotension ensued and was first treated with resusci-
tation and placement of a left ventricular assist device.
Subsequently, a guide wire was passed into the left main cor-
onary artery (Figure 11, C) and a bifurcating stent was placed
to keep the left main coronary artery open (Figure 11, D).
This patient left the hospital a few days later with a well func-
tioning aortic valve and is fine, but the implantation team and
patient were a short step away from disaster. A vascular sur-970 The Journal of Thoracic and Cardiovascular Surgery c Mageon, a cardiac surgeon, an interventional cardiologist, and
an echocardiographer were all involved in this case, and
the skills of each of them were essential for a safe outcome.
The following sequence shows a transapical aortic valve
being placed by my colleague, Dr Lars Svensson, with the
assistance of a cardiothoracic anesthesiologist doing transe-
sophageal echocardiography and a cardiologist helping
with fluoroscopy (Figure 12, A toC). There are many theoret-
ical advantages of transapical access to the aortic valve. It
avoids having to place a catheter through a long, circuitous
route through an atherosclerotic aorta, and it should allowy 2008
Lytle Presidential AddressFigure 11. Patient with calcific aortic stenosis treated with a catheter-borne aortic valve prosthesis (A), resulting in
left main coronary artery occlusion (B). After a guide wire was placed in the left main coronary artery (C), a bifur-
cated stent was placed re-establishing flow to the left main, left anterior descending, and circumflex coronary
arteries (D). Multiple skill sets are needed to optimize safety during these complex procedures.more accurate control of the catheter and device placement.
In Figure 12, B, the valve is fixed in place as Dr Svensson
inflates the balloon. The postprocedure angiogram shows
only slight aortic insufficiency (Figure 12, C).
The apex is not the only place at which cardiac surgeons
can access the beating heart. In theory, this should be able
to be done through the right atrium or left atrium with cathe-
ter-borne devices that can accomplish mitral annuloplasties
and possibly close septal defects or periprosthetic leaks with
the heart beating (Figure 13). It is reasonably easy to imagine
types of operations that might be accomplished with the aid of
minimally invasive robot-assisted strategies, and I think this
type of approach is a fruitful area of investigation. Robotic
technology has made strong progress. With the development
of parallel anastomotic technologies and possibly in combina-
tion with catheter-borne devices, there is a great future in this
area. Robotics is not dead. Combinations of these technolo-The Journal of Thogies offer the possibility of providing cardiac surgeons with
a complex platform that will allow access to all cardiac cham-
bers and the performance of multiple intracardiac procedures.
The transvascular route is not the only way to get catheter-
borne devices into the heart to treat structural heart disease.
The catheter-borne valve devices available today are first-
generation efforts and our experience is limited, but lessons
have already been learned. First, some of these procedures
produce good outcomes even today for individual patients
over the short term. Second, device improvement is likely
to be very rapid. Third, vascular complications are a substan-
tial source of risk. Fourth, accurate imaging is critical for
consistent success, and multiple imaging modalities can be
very helpful. For example, Figure 14 is a 4-dimensional com-
puted tomographic image of a bicuspid aortic valve. Today,
this technique cannot be used in an operating room in real
time, but I believe that will come and that this type of imagingracic and Cardiovascular Surgery c Volume 135, Number 5 971
Presidential Address LytleFigure 12. Dr Lars Svensson, cardiothoracic surgeon, and Dr Murat Tuzcu, interventional cardiologist (A), collabo-
rate in placing a catheter-borne aortic valve at The Cleveland Clinic Foundation. After placement of the aortic valve
prosthesis (B), postoperative angiography shows little evidence of a periprosthetic leak (C).not only will allow us to understand better which patients are
most appropriate for the placement of catheter-borne devices,
but eventually will help us place these devices. Fifth, the
operating room is the ideal location for combining multiple
imaging capabilities with multiple therapeutic strategies
and devices. Sixth, a variety of skill sets and experience is
needed to carry out these procedures with the highest degree
of accuracy and safety.
Catheter-borne valve devices are going to work. They work
today. They are not going to replace open surgery in the near
future, but they will have an impact. Some of the questions that
we have to answer now are as follows: What does this have to
do with us? Do we want to and do we think we can perform
these procedures? Shouldn’t we leave these to physicians
who have only catheter skills? What is it that we can add?
I believe that it is in the interest both of patients and of prog-
ress in the treatment of structural heart disease for cardiac972 The Journal of Thoracic and Cardiovascular Surgery c Maysurgeons to be personally involved in performing these proce-
dures. First of all, our skills and experience in perfusion, myo-
cardial protection, cerebral protection, robotics, and open
surgery will allow the maximal use of these technologies
and will allow them to be taken to their highest level. The op-
erating room is the safest location for the use of these devices
so long as that operating room has imaging capabilities that are
state of the art. Cardiac surgeons have the most to add when
new technologies are applied to complex problems. We are
not going to displace either cardiologists from coronary stent-
ing or vascular surgeons from iliac or carotid stenting. There
are not enough of us to do these procedures even if we wanted
to, and we do not add much to relatively straightforward
catheterization laboratory type procedures. Sometimes it
is possible to achieve good outcomes with a simple catheteri-
zation laboratory approach, but not always. The operating
room does add safety, and it also allows the possibility for2008
Lytle Presidential Addressmultiple interventional technologies and interventional proce-
dures combined with open surgery to be used in combination.
Second, if our opinions are going to carry any weight
regarding the use of these devices, we are going to have to
be able to use them ourselves. The posture of one group of
Figure 13. The transvascular route is not the only access to
cardiac chambers for the delivery of catheter-borne devices.
Figure 14. Accurate imaging is critical for successful minimally
invasive and catheter-borne operations, particularly if they
involve the beating heart. This 4-dimensional computed tomo-
graphic image allows very accurate localization of the calcium
on a bicuspid aortic valve.The Journal of Thophysicians telling another group of physicians when to use
or not use a technology has not worked well in the past and
is unlikely to work well in the future. Decision-making is
rarely ideal, acrimony is inevitable, and patient care suffers.
To allow the best choice of procedure, it helps to be able to
perform all procedures, if not by an individual, then at least
by a unified group.
Now, let’s shift gears for a second. An important point for
us to consider is that increasing our scope of practice cannot
just mean using a bunch of new technologies. We need to
think about altering our model of practice to allow more
interaction with patients before procedures and during
follow-up and to achieve more total disease management,
to use a current phrase. If we look back at the early years
of cardiac surgery, what we might term the research and
development years, surgeons were the dominant breed of
cardiovascular physiologists and often played a significant
role in preoperative management, even performing diagnos-
tic catheterizations. Realistically, part of the reason for that
was that cardiology was a fairly undeveloped specialty at
that time. With the onset of coronary surgery, cardiac sur-
geons became extremely operating room centered and totally
uninvolved in coronary angiography, the only form of imag-
ing at that time. That was a very efficient way to do things
when there were limited choices of technologies. We are,
after all, surgeons and we like to work in the operating
room. But that meant that the choice of treatment, at that
time surgical versus medical management, evolved largely
into the hands of cardiologists. As we now know, that situa-
tion was to have tremendous impact once there were cardiol-
ogist-driven, catheter-borne therapeutic alternatives.
In other areas of cardiovascular disease, that sequence did
not play out. For example, in the management of thoracic aor-
tic disease, cardiothoracic surgeons have long been involved
in total disease management, including diagnosis, follow-up,
and sometimes eventual surgery. This model can be extended
to valvular heart disease. Now the question arises, isn’t that
what cardiologists do? Well, not necessarily. In many prac-
tice settings, the emphasis of cardiology is very much away
from disease management and very much toward interven-
tion. Today, relatively few cardiology fellows are interested
in going into clinical cardiology, only 16% in an American
College of Cardiology survey, whereas programs offering
training in interventional cardiology or in electrophysiology
are oversubscribed. It is also important to appreciate the sub-
stantial progress that has been made in non–catheter-based
imaging, including computed tomographic scanning, mag-
netic resonance imaging, echocardiography, and positron
emission tomography, alone and in combination. These im-
aging strategies will greatly aid surgeons in the preoperative
assessment and postoperative follow-up of patients with
valvular heart disease. The model of disease management
will have consistency and longevity in a world of multiple
and changing interventional technologies.racic and Cardiovascular Surgery c Volume 135, Number 5 973
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invasive technologies will not be easy, but we must take
those steps. Damon Runyon was a great American author
and the source of considerable wisdom. To quote Damon
Runyon, ‘‘Son, don’t play ’em unless you got ’em.’’ And,
right now, we ain’t got ’em. Or at least we ain’t got enough
of ’em. For us to get to where we need to get will take dedi-
cated individuals who will commit themselves to a new
career direction, spend significant amounts of time to be
able to use new technologies at a high level, and develop
practices. Everything else stems from that. When it is possi-
ble, we need to learn from physicians who currently have
these skills, regardless of their specialty. It will be difficult
to be alone in educating ourselves, and I do not think we
have to be. At The Cleveland Clinic we are very fortunate
to work with cardiologists and vascular surgeons who have
a vision of a collaborative effort and can see the unique capa-
bilities that cardiac surgeons add to the team and add to the
technology. I certainly realize that those relationships do
not exist every place, but the principle of enlisting and collab-
orating with skilled physicians who are not cardiothoracic
surgeons is not wise to abandon. For our part, we also need
to be collegial, to help these other specialties understand
that we are not trying to develop competitive practices
in isolated coronary interventions or peripheral vascular
disease, but that we are trying to expand the use of these tech-
nologies to treat complex heart and vascular disease.
It is not only the surgeons learning these techniques who
will need to be committed, but there must be support from
their colleagues and the organizations employing them.
That support must be both financial and programmatic. These
technologies involve different skill sets, will need a lot of
concentration, and will continue a trend toward the subspeci-
alization of cardiothoracic surgery. Our skill level in using all
devices will need to be very high. We will not be able to con-
tribute if we are second rate users of new technologies, and
the exact role cardiac surgeons will play in using them will
depend on how good we get at it. Increasing the scope of
practice of the specialty will at times mean a decrease in
the scope of the practice of the individual, but it must be so.
This increasing subspecialization is also likely to point to-
ward more practice consolidation and toward regionalization.
Even with the relatively standard cardiac surgical procedures
that are done today, there are multiple studies that show that
outcomes are volume-dependent. The same will be true of
these procedures, perhaps more so.
Our professional organizations, the AATS and the STS,
need to contribute to our move into the future and, in fact,
they have been contributing. One of the most rewarding
things about my involvement with both our professional
organizations has been to interact with the many fine sur-
geons who spend such an enormous amount of time to better
this specialty and improve patient care. These are volunteers
and they all have day jobs and they make enormous commit-974 The Journal of Thoracic and Cardiovascular Surgery c Maments. The collegiality of Fred Grover and John Mayer, the
two STS presidents during my tenure at the AATS, has
been tremendous, as it has been from the entire group of
the STS leadership—and we had better continue to be colle-
gial, because we have a lot that we need to accomplish
together. Both organizations have made initial efforts in the
very important area of establishing training sessions and
educational programs to help practicing surgeons become
familiar with new horizons and new technologies. These
programs are not going to substitute for long-term institu-
tion-based training, but they are useful today and they will
be even more so as the issues in the future relate to the famil-
iarity with a multiplicity of devices. Some of our partners in
industry have stepped up with the development and the fund-
ing of new teaching technologies, such as simulators, and
have constructed programs to help surgeons make progress
with these catheter-borne technologies. This is great, but it
is also expensive. This is an area in which it makes sense
for the AATS and the STS to combine their efforts and
conjointly develop sessions to make this training more
efficient for surgeons and more efficient and less costly for
our partners in industry.
Another area in which we need to be on the same page is in
the development of our future relationships with our vascular
surgical colleagues. The interface between vascular surgery
and cardiac surgery is extremely variable and sometimes con-
tentious. If we were designing a system of practice and train-
ing from scratch, I doubt that today we would separate
cardiothoracic surgery and vascular surgery. Some places
never have, to their great benefit. There are vascular surgeons
who have skills and experience that can be of great benefit to
us as we attempt to design and apply new treatments for car-
diovascular disease, including new treatments for heart dis-
ease. The AATS is an association for thoracic surgery, not
of thoracic surgeons. Our founders were wise to make that
distinction, and we will advance the care of patients faster
if we take advantage of the talents of physicians dedicating
themselves to the treatment of cardiovascular disease, regard-
less of which Board examination they have passed. Cardio-
thoracic surgery and vascular surgery are not going to meld
together over night, but it is in all of our interest for the
AATS and the STS together to develop a common plan for
evaluating this possibility.
One of the most perplexing issues we have been forced to
deal with has been the recent lack of interest in our specialty
by young surgeons. To many of us, including me, this is mys-
tifying. More objective observers than I am have pointed out
that today’s young physicians may be put off by the long train-
ing commitment, the demanding lifestyle of cardiac surgeons,
combined with the lack of a defined vision for the future of
a specialty, and the fear of a poor job market at the end of their
training. This is certainly logical thinking. On the other hand,
most of us did not become cardiac surgeons because of logic.
We did it because of a passion; we found that we loved it.y 2008
Lytle Presidential AddressWhen I was a young general surgery resident, one of my se-
nior residents asked me what I was interested in. When I
told him cardiac surgery, he replied ‘‘Well, I can understand
that but, don’t worry, you’ll grow out of it.’’ But, I never
did. As the years have passed, I think it has become apparent
to many of us that you do cardiac surgery somewhat with your
brain and you do it somewhat with your hands, but mostly you
do cardiac surgery with your heart.
There are things about cardiac surgery that we can change
to make it more appealing to medical students and residents.
The length, difficulty, and inefficiency of our training have
been cited as issues, and we can make training more efficient.
We now can re-engineer residency programs. The potential
models for cardiothoracic training programs extend from
what is standard today: a lot of general surgery, followed
by 2 or 3 years of cardiothoracic surgery, to a total, straight
out of medical school, cardiovascular and thoracic training
program lasting at least 6 years. At this point, relatively
few programs have actually changed, and those that have
are in the early stages of enrolling residents. Thus we do
not know what model of training will work the best. We
need to follow these experiments very carefully to study their
effectiveness in attracting and training candidates.
Whatever the exact model, what making our programs
more efficient really means is a longer, more fruitful period
of involvement with cardiovascular disease. The earlier the
exposure to cardiac surgery, the more likely the young phy-
sician will fall in love with it. This year, the AATS initiated
a scholarship program for medical students to try to expose
them to cardiac surgery and cardiovascular disease at an early
stage of their career. It is our hope that these students will be
able to feel the passion and the joy that we have experienced.
So far the response has been overwhelming, but only time
will tell whether this is effort is successful.
Regardless of how we shape it, residency training is
always going to be a major commitment. If we think about
what we have been saying about the scope of teaching and
practice, it must include total disease management, critical
care, expertise in imaging, open surgery involving adult
and congenital cardiac disease, vascular surgery, general tho-
racic surgery, catheter-borne endografting, catheter-borne
valve repair and replacement technologies, coronary angiog-
raphy, and perfusion. Now, that is a lot. So, although we may
be able to make residency training more efficient and more
focused on cardiovascular disease, we may not be able to
make it easier or overall much shorter.
Sociologists tell us that the millennium generation, those
young adults now in their 20s who make up our current gener-
ation of trainees, express different career motivations than has
been true of past generations. Without going into great depth
on the details, it appears that they place a lot of value on a
limited career commitment, both in time and intensity, value
time spent with their families, and like the possibility of having
multiple careers during their lifetime. These characteristics areThe Journal of Thornot a great match for our specialty, which has a long period of
training, a long career focus, the need for technical excellence,
the assumption of personal responsibility, and the need for
continued growth in expertise throughout one’s career.
The fundamental problem that we face is that cardiac
surgery is hard. Sometimes it is really hard. And, people
with a limited commitment usually do not get very good at
it. We really cannot change that. Maybe in the future there
will be niches for people to fit into using limited technologies
on limited problems that require only a limited commitment.
However, technology will change, and training surgeons in
limited technologies is likely to run out. The field of cardiac
surgery will not be advanced by people with a niche focus or
a limited commitment.
Even during the most popular years of cardiac surgery,
most physicians were not a good match. Theognis, speaking
centuries ago, observed, ‘‘In a serious business a man’s com-
panions are few.’’ It has been that way in the past, it is the
same today, and we will not be able to make it otherwise.
We are not going to be able to train meadowlarks to be eagles.
What we have to do is to find the eagles, and there are eagles
out there. Once we find them, we have to show them a vision
of what their careers can be should they make the commit-
ment and show them a path that they can look down and
see a way to get to their goal. We must be able to show
them the future relevance of cardiac surgery to the treatment
of heart disease, the relevance of the operations we do today,
and the relevance of the operations that we will do in the
future. We must be able to show them the relevance of
understanding the diseases as well as understanding the
technologies.
What we will be in the future is, we will be better. We will
make the treatment of heart disease safer, more efficient, less
invasive, and more effective. We can do that by improving
those skills that are at our core today, complex open surgery,
perfusion, critical care, and we can do that by exploring those
technologies that have not been our core. Our unique role will
not be battling other specialties for the application of these
technologies to simple problems, but elevating them to
contribute to the solution of the more complex. What our
core values will be in the future is what our core values
have been in the past—seriousness, personal responsibility,
technical excellence, intellectual credibility, leadership, and
mentoring. Technologies are going to change, but those
values will outlast them.
It has been a great honor for me to speak with you today
and to have spent my career with you. We share much that
is truly inspiring. Only we know how wonderful it is to be
able to go into the operating room, to hold in our hands a dam-
aged heart, to be able to reconstruct it, and to allow someone
a longer life and more happiness. Cardiac surgery has
provided our lives with a great purpose and with profound
meaning. We owe much for this and, God willing, I look
forward to an exciting future with you.acic and Cardiovascular Surgery c Volume 135, Number 5 975
